109 related articles for article (PubMed ID: 8068301)
1. Calcium-enhanced aggregation of serum amyloid P component and its inhibition by the ligands heparin and heparan sulphate. An electron microscopic and immunoelectrophoretic study.
Nielsen EH; Sørensen IJ; Vilsgaard K; Andersen O; Svehag SE
APMIS; 1994 Jun; 102(6):420-6. PubMed ID: 8068301
[TBL] [Abstract][Full Text] [Related]
2. Native human serum amyloid P component is a single pentamer.
Sørensen IJ; Andersen O; Nielsen EH; Svehag SE
Scand J Immunol; 1995 Mar; 41(3):263-7. PubMed ID: 7871385
[TBL] [Abstract][Full Text] [Related]
3. Human serum amyloid P component is a single uncomplexed pentamer in whole serum.
Hutchinson WL; Hohenester E; Pepys MB
Mol Med; 2000 Jun; 6(6):482-93. PubMed ID: 10972085
[TBL] [Abstract][Full Text] [Related]
4. Calcium-dependent polymerization of human serum amyloid P component is inhibited by heparin and dextran sulfate.
Hamazaki H
Biochim Biophys Acta; 1989 Oct; 998(3):231-5. PubMed ID: 2478195
[TBL] [Abstract][Full Text] [Related]
5. Binding of serum amyloid P component to heparin in human serum.
Li XA; Hatanaka K; Guo L; Kitamura Y; Yamamoto A
Biochim Biophys Acta; 1994 Nov; 1201(2):143-8. PubMed ID: 7947925
[TBL] [Abstract][Full Text] [Related]
6. Serum amyloid P component binds to influenza A virus haemagglutinin and inhibits the virus infection in vitro.
Andersen O; Vilsgaard Ravn K; Juul Sørensen I; Jonson G; Holm Nielsen E; Svehag SE
Scand J Immunol; 1997 Oct; 46(4):331-7. PubMed ID: 9350282
[TBL] [Abstract][Full Text] [Related]
7. Binding of Ca2+, Mg2+, and heparin by human serum amyloid P component in affinity capillary electrophoresis.
Heegaard NH; He X; Blomberg LG
Electrophoresis; 2006 Jul; 27(13):2609-15. PubMed ID: 16817162
[TBL] [Abstract][Full Text] [Related]
8. Pentameric and decameric structures in solution of serum amyloid P component by X-ray and neutron scattering and molecular modelling analyses.
Ashton AW; Boehm MK; Gallimore JR; Pepys MB; Perkins SJ
J Mol Biol; 1997 Sep; 272(3):408-22. PubMed ID: 9325100
[TBL] [Abstract][Full Text] [Related]
9. Investigating interactions of the pentraxins serum amyloid P component and C-reactive protein by mass spectrometry.
Aquilina JA; Robinson CV
Biochem J; 2003 Oct; 375(Pt 2):323-8. PubMed ID: 12892563
[TBL] [Abstract][Full Text] [Related]
10. Heparin influence on the complex of serum amyloid P component and complement C4b-binding protein.
Schwalbe RA; Dahlbäck B; Nelsestuen GL
J Biol Chem; 1991 Jul; 266(20):12896-901. PubMed ID: 2071579
[TBL] [Abstract][Full Text] [Related]
11. The Pentraxins 1975-2018: Serendipity, Diagnostics and Drugs.
Pepys MB
Front Immunol; 2018; 9():2382. PubMed ID: 30459761
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of fibrin polymerization by serum amyloid P component and heparin.
Meyer K; Smith R; Williams EC
Thromb Haemost; 1987 Jun; 57(3):345-8. PubMed ID: 3660334
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of a decameric complex of human serum amyloid P component with bound dAMP.
Hohenester E; Hutchinson WL; Pepys MB; Wood SP
J Mol Biol; 1997 Jun; 269(4):570-8. PubMed ID: 9217261
[TBL] [Abstract][Full Text] [Related]
14. Calcium-mediated hemagglutination by serum amyloid P component and the inhibition by specific glycosaminoglycans.
Hamazaki H
Biochem Biophys Res Commun; 1988 Jan; 150(1):212-8. PubMed ID: 3276308
[TBL] [Abstract][Full Text] [Related]
15. Serum amyloid P component promotes formation of distinct aggregated lysozyme morphologies and reduces toxicity in Drosophila flies expressing F57I lysozyme.
Bergkvist L; Richards DR; Bernardo-Gancedo A; Kumita JR; Nilsson PR; Brorsson AC
PLoS One; 2020; 15(1):e0227227. PubMed ID: 31978114
[TBL] [Abstract][Full Text] [Related]
16. Interaction between serum amyloid P component and C4b-binding protein associated with inhibition of factor I-mediated C4b degradation.
García de Frutos P; Dahlbäck B
J Immunol; 1994 Mar; 152(5):2430-7. PubMed ID: 8133054
[TBL] [Abstract][Full Text] [Related]
17. Calcium-dependent and -independent binding of the pentraxin serum amyloid P component to glycosaminoglycans and amyloid proteins: enhanced binding at slightly acid pH.
Danielsen B; Sørensen IJ; Nybo M; Nielsen EH; Kaplan B; Svehag SE
Biochim Biophys Acta; 1997 Apr; 1339(1):73-8. PubMed ID: 9165101
[TBL] [Abstract][Full Text] [Related]
18. Purification, subunit characterization and ultrastructure of three soluble bovine lectins: conglutinin, mannose-binding protein and the pentraxin serum amyloid P-component.
Andersen O; Friis P; Holm Nielsen E; Vilsgaard K; Leslie RG; Svehag SE
Scand J Immunol; 1992 Jul; 36(1):131-41. PubMed ID: 1319609
[TBL] [Abstract][Full Text] [Related]
19. Binding of complement proteins C1q and C4bp to serum amyloid P component (SAP) in solid contra liquid phase.
Sørensen IJ; Nielsen EH; Andersen O; Danielsen B; Svehag SE
Scand J Immunol; 1996 Oct; 44(4):401-7. PubMed ID: 8845035
[TBL] [Abstract][Full Text] [Related]
20. Serum Amyloid P Component (SAP) Interactome in Human Plasma Containing Physiological Calcium Levels.
Poulsen ET; Pedersen KW; Marzeda AM; Enghild JJ
Biochemistry; 2017 Feb; 56(6):896-902. PubMed ID: 28098450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
